Literature DB >> 12845619

The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis.

Sylvia Heeneman1, Jack P Cleutjens, Birgit C Faber, Esther E Creemers, Robert-Jan van Suylen, Esther Lutgens, Kitty B Cleutjens, Mat J Daemen.   

Abstract

The extracellular matrix is no longer seen as the static embedding in which cells reside; it has been shown to be involved in cell proliferation, migration and cell-cell interactions. Turnover of the different extracellular matrix components is an active process with multiple levels of regulation. Collagen, a major extracellular matrix constituent of the myocardium and the arterial vascular wall, is synthesized by (myo)fibroblasts in the myocardium and smooth muscle cells in the medial arterial vascular wall. Its degradation is controlled by proteinases, which include matrix metalloproteinases. This review will focus on the impact of fibrosis and especially collagen turnover on the progression of heart failure and atherosclerosis, two of the main cardiovascular pathologies. We will discuss data from human studies and animal models, with an emphasis on the effects of interventions on collagen synthesis and degradation. We conclude that there is a dynamic (dis)balance in the rate of collagen synthesis and degradation during heart failure and atherosclerosis, which makes the outcome of interventions not always predictable. Alternative approaches for intervening in collagen metabolism will be discussed as possible therapeutic intervention strategies. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12845619     DOI: 10.1002/path.1395

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  30 in total

Review 1.  Extra-cellular matrix in vascular networks.

Authors:  George Bou-Gharios; Markella Ponticos; Vineeth Rajkumar; David Abraham
Journal:  Cell Prolif       Date:  2004-06       Impact factor: 6.831

Review 2.  Fetal hypoxia and programming of matrix metalloproteinases.

Authors:  Wenni Tong; Lubo Zhang
Journal:  Drug Discov Today       Date:  2011-09-18       Impact factor: 7.851

3.  Cardiomyocyte cell cycle activation ameliorates fibrosis in the atrium.

Authors:  Hidehiro Nakajima; Hisako O Nakajima; Klaus Dembowsky; Kishore B S Pasumarthi; Loren J Field
Journal:  Circ Res       Date:  2005-11-23       Impact factor: 17.367

4.  Effects of interleukin-33 on cardiac fibroblast gene expression and activity.

Authors:  Jinyu Zhu; Wayne Carver
Journal:  Cytokine       Date:  2012-03-23       Impact factor: 3.861

5.  Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice.

Authors:  Aaron M Firoved; Georgina F Miller; Mahtab Moayeri; Rahul Kakkar; Yuequan Shen; Jason F Wiggins; Elizabeth M McNally; Wei-Jen Tang; Stephen H Leppla
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

6.  Interaction of cowpea mosaic virus nanoparticles with surface vimentin and inflammatory cells in atherosclerotic lesions.

Authors:  Emily M Plummer; Diane Thomas; Giuseppe Destito; Leah P Shriver; Marianne Manchester
Journal:  Nanomedicine (Lond)       Date:  2012-03-06       Impact factor: 5.307

7.  Extracellular matrix proteins and matrix metalloproteinases differ between various right and left ventricular sites in end-stage cardiomyopathies.

Authors:  E Herpel; S Singer; C Flechtenmacher; M Pritsch; F-U Sack; S Hagl; H A Katus; M Haass; H F Otto; P A Schnabel
Journal:  Virchows Arch       Date:  2005-04-02       Impact factor: 4.064

8.  MT1-MMP regulates the turnover and endocytosis of extracellular matrix fibronectin.

Authors:  Feng Shi; Jane Sottile
Journal:  J Cell Sci       Date:  2011-12-08       Impact factor: 5.285

9.  Maternal hypoxia alters matrix metalloproteinase expression patterns and causes cardiac remodeling in fetal and neonatal rats.

Authors:  Wenni Tong; Qin Xue; Yong Li; Lubo Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-19       Impact factor: 4.733

10.  Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation.

Authors:  Keren Borensztajn; Jurriën Stiekema; Sebastiaan Nijmeijer; Pieter H Reitsma; Maikel P Peppelenbosch; C Arnold Spek
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.